Ameriprise
LEGN icon

Ameriprise’s Legend Biotech LEGN Stock Holding History

Ameriprise’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.21M Buy
249,767
+174,328
+231% +$4.7M ﹤0.01% 2294
2026
Q1 		$1.36M Buy
75,439
+377
+0.5% +$7.19K ﹤0.01% 3151
2025
Q4 		$1.63M Sell
75,062
-467,260
-86% -$13.4M ﹤0.01% 3106
2025
Q3 		$17.7M Sell
542,322
-85,863
-14% -$3.17M ﹤0.01% 1494
2025
Q2 		$22.3M Sell
628,185
-28,963
-4% -$939K 0.01% 1276
2025
Q1 		$22.3M Sell
657,148
-109,292
-14% -$3.92M 0.01% 1239
2024
Q4 		$24.9M Buy
766,440
+52,939
+7% +$2.19M 0.01% 1195
2024
Q3 		$34.8M Buy
713,501
+56,114
+9% +$2.99M 0.01% 1032
2024
Q2 		$29.1M Buy
657,387
+563,668
+601% +$26M 0.01% 1053
2024
Q1 		$5.26M Sell
93,719
-4,169
-4% -$251K ﹤0.01% 2333
2023
Q4 		$5.89M Buy
97,888
+41,741
+74% +$2.65M ﹤0.01% 2226
2023
Q3 		$3.77M Buy
56,147
+19,889
+55% +$1.38M ﹤0.01% 2495
2023
Q2 		$2.5M Buy
+36,258
New +$2.37M ﹤0.01% 2767
2023
Q1 		– Sell
-241,150
Closed -$12M – 3996
2022
Q4 		$12M Sell
241,150
-59,446
-20% -$2.88M ﹤0.01% 1589
2022
Q3 		$12.3M Buy
+300,596
New +$14.1M ﹤0.01% 1508

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Ameriprise's LEGN Position: Q2 2026 in Review

Ameriprise increased its Legend Biotech (LEGN) stake by 231% in Q2 2026, buying an estimated $4.7M and bringing the position to 249,767 shares worth $7.21M. The position accounts for ﹤0.01% of the portfolio, ranked #2294.

Ameriprise first reported a position in LEGN in Q3 2022 and has held it in 15 quarters since. The position peaked at $34.8M in Q3 2024. 219 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.

  • Ameriprise held 249,767 shares of Legend Biotech worth $7.21M as of Q2 2026.
  • Ameriprise bought 174,328 Legend Biotech shares in Q2 2026, an estimated $4.7M.
  • Legend Biotech made up ﹤0.01% of Ameriprise's portfolio in Q2 2026, its #2294 holding.
  • Ameriprise first reported a position in Legend Biotech in Q3 2022 and has held it in 15 quarters since.
  • Ameriprise's Legend Biotech position peaked at $34.8M in Q3 2024.
  • 219 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.

Based on Ameriprise's 13F filing for Q2 2026, filed 14 Aug 2026.